文献速递糖尿病

改善2型糖尿病用药依从性:优化临床与经济结局的策略

Improving medication adherence in type 2 diabetes: strategies for better clinical and economic outcomes.
PubMed 文献 · Diabetologia · 2025-11-28

本综述综合2型糖尿病用药不依从的患病率、危险因素及临床与经济后果,并评估改善依从性的干预措施。全球约38%的2型糖尿病患者未按处方用药,不依从与HbA1c升高、并发症、住院和死亡风险增加及高医疗费用相关。药师主导照护和固定剂量复方制剂有益,技术和动机策略结果不一,多层面个体化干预似乎最有效。

要点

  • 全球约38%的2型糖尿病患者未按处方用药,估计值因多种因素差异大。
  • 不依从与HbA1c升高、微血管和大血管并发症、住院、死亡及高医疗费用相关。
  • 药师主导照护和固定剂量复方制剂有益,多层面个体化干预似乎最有效。

核心结论

  • 用药不依从在2型糖尿病中普遍且与不良临床与经济结局相关。
  • 药师主导照护和固定剂量复方制剂显示有益,多层面个体化干预似乎最有效。

研究设计与样本

  • 综述综合2型糖尿病用药不依从的患病率、危险因素、临床与经济后果及改善依从性的干预证据。

主要发现

  • 全球估计约38%的2型糖尿病患者未按处方用药,估计值因患者相关、社会经济、疾病相关和医疗系统因素差异大。
  • 不依从与HbA1c升高、微血管和大血管并发症、住院和死亡风险增加相关,并带来高医疗费用。
  • 评估方法从主观自我报告到客观生化检测不等,后者在研究 and 临床实践中日益突出。
  • 已研究干预包括教育、技术、药师主导、行为、财务策略和固定剂量复方制剂。
  • 药师主导照护和固定剂量复方制剂有益,技术和动机策略结果不一;共享决策和认知行为治疗可能额外获益。

临床怎么用

  • 可考虑药师主导照护和固定剂量复方制剂以改善依从性。
  • 对多重长期疾病或心理共病患者,共享决策和认知行为治疗可能提供额外获益。
  • 采用多层面、针对个体障碍并持续进行的干预可能最有效。

局限性

  • 不依从估计值因多种因素差异大。
  • 技术和动机策略的结果仍不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Medication adherence is critical for optimal glycaemic management and the prevention of complications in type 2 diabetes mellitus. Despite its importance, non-adherence remains a prevalent issue, with global estimates suggesting that approximately 38% of people with type 2 diabetes do not take their medications as prescribed, although estimates vary widely due to a range of patient-related, socioeconomic, condition-related (e.g. chronicity, severity of comorbidities) and healthcare system factors. This review synthesises the current evidence on the prevalence of non-adherence in type 2 diabetes, as well as risk factors and clinical and economic consequences, and evaluates interventions designed to improve adherence in this population. Medication non-adherence is associated with increased HbA1c levels and risks of micro- and macrovascular complications, hospitalisation and mortality, while also incurring substantial healthcare costs. Methods for assessing medication adherence range from subjective self-report tools to objective measures such as biochemical testing, which are gaining prominence in both research and clinical practice. Numerous interventions to increase medication adherence have been investigated, including educational, technological, pharmacist-led, behavioural and financial strategies and fixed-dose combination (FDC) therapies. While interventions such as pharmacist-led care and FDC therapies are beneficial, outcomes from technology-based and motivational strategies remain mixed. Shared decision making and behavioural interventions, such as cognitive behavioural therapy, may provide additional benefits, particularly for individuals with multiple long-term conditions or psychological comorbidities. Multifaceted interventions tailored to individual barriers and sustained over time appear most effective. Given the significant impact of non-adherence on both patient outcomes and healthcare systems, future research is needed to design personalised, multicomponent interventions that are scalable and equitable across diverse healthcare settings.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Highton PJ, Funnell MP, Gupta P, et al. Improving medication adherence in type 2 diabetes: strategies for better clinical and economic outcomes. Diabetologia. 2025. PMID: 41315090. doi:10.1007/s00125-025-06617-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。